Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.

N Katsumata, K Noda, S Nozawa, R Kitagawa, R Nishimura, S Yamaguchi, D Aoki, N Susumu, H Kuramoto, T Jobo, K Ueki, M Ueki, I Kohno, K Fujiwara, Y Sohda, F Eguchi

Journal: British journal of cancer 2005;93(9):999-1004

PMID: 16234823

Free Full Text on PubMed Central View on PubMed

Abstract

The purpose of this study was to determine whether docetaxel has antitumour activity in patients with advanced or recurrent endometrial carcinoma. Chemotherapy-naïve or previously treated patients (one regimen) with histopathologically documented endometrial carcinoma and Eastern Cooperative Oncology Group performance status

Address: Department of Medical Oncology, National Cancer Center Hospital, 104-0045 Tokyo, Japan. [email protected]

DOI: 10.1038/sj.bjc.6602817

Link outs

Free resources

Full Text Sources:

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-PGR-1

Subscription / membership required

Full Text Sources:

https://doi.org/10.1038/sj.bjc.6602817

MeSH Terms: Adenocarcinoma, Adenocarcinoma, Papillary, Adult, Aged, Antineoplastic Agents, Phytogenic, Carcinoma, Squamous Cell, Cystadenocarcinoma, Serous, Docetaxel, Endometrial Neoplasms, Female, Humans, Japan, Middle Aged, Neoplasm Recurrence, Local, Salvage Therapy, Survival Rate, Taxoids